Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Azithromycin in gonorrhoea

M A Waugh1

  • 1Leeds General Infirmary, UK.

International Journal of STD & AIDS
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Azithromycin is a globally recommended antibiotic for treating gonorrhoea, especially when co-infected with Chlamydia trachomatis. Its single-dose effectiveness makes it ideal for acute therapy, even without immediate lab confirmation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Threadworm: an infrequent clinical finding in a genitourinary medicine clinic attendee presenting with ano-genital irritation.

International journal of STD & AIDS·2009
Same author

Oral Kaposi's sarcoma in a non-HIV homosexual White male.

International journal of STD & AIDS·2004
Same author

Prevalence of asymptomatic chlamydial urethritis in military recruits in the Celje region, Slovenia.

International journal of STD & AIDS·2003
Same author

An audit of the 'two glass' test of urethritis.

International journal of STD & AIDS·2001
Same author

Syphilis in Slovenia--on the threshold of the European Union.

International journal of STD & AIDS·2001
Same author

Epidemiology of syphilis in Bulgaria, 1990-1998.

International journal of STD & AIDS·2001

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Microbiology

Background:

  • Gonorrhoea is frequently co-infected with Chlamydia trachomatis.
  • Effective antibiotic treatment is crucial for managing these sexually transmitted infections.
  • Azithromycin has emerged as a significant therapeutic option.

Purpose of the Study:

  • To review the clinical applications of azithromycin in gonorrhoea treatment.
  • To compare European clinical trials with a recent US study on azithromycin efficacy.
  • To highlight the advantages of azithromycin in gonorrhoea management.

Main Methods:

  • Review of clinical trials from European centers.
  • Analysis of a large, recent US study on azithromycin.
  • Comparison of study findings regarding azithromycin's effectiveness.

Related Experiment Videos

Main Results:

  • Azithromycin is recommended worldwide for gonorrhoea treatment.
  • Single-dose azithromycin therapy is a key advantage.
  • Effective even when the causative pathogen is uncertain, aiding acute therapy.

Conclusions:

  • Azithromycin is a valuable antibiotic for gonorrhoea, particularly with co-infections.
  • Its utility in uncertain etiological cases and single-dose administration is emphasized.
  • Azithromycin facilitates effective acute management of gonorrhoea.